5'-Guanidinonaltrindole, a highly selective and potent κ-opioid receptor antagonist

Robert M. Jones, Philip S. Portoghese

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Abstract

5'-Guanidinonaltrindole (GNTI) possesses 5-fold greater opioid antagonist potency (K(e)=0.04 nM) and an order of magnitude greater selectivity (selectivity ratios >500) than the prototypical κ-opioid receptor antagonist, norbinaltorphimine, in smooth muscle preparations. Binding and functional studies conducted on cloned human opioid receptors expressed in Chinese hamster ovarian (CHO) cells afforded pA2 values that were comparable to the smooth muscle data. In view of the high selectivity and potency of GNTI, it is a potentially valuable pharmacological tool for opioid research. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)49-52
Number of pages4
JournalEuropean Journal of Pharmacology
Volume396
Issue number1
DOIs
StatePublished - May 12 2000

Keywords

  • Binding
  • Norbinaltorphimine
  • κ-Opioid receptor

Fingerprint Dive into the research topics of '5'-Guanidinonaltrindole, a highly selective and potent κ-opioid receptor antagonist'. Together they form a unique fingerprint.

Cite this